Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of eldecalcitol monotherapy
compared with alfacalcidol monotherapy in patients with glucocorticoid-induced osteoporosis,
using a randomized, open-label, parallel-group, comparative design.
Phase:
N/A
Details
Lead Sponsor:
e-GLORIA trial Protocol Review Committee
Treatments:
Alfacalcidol Eldecalcitol Glucocorticoids Hydroxycholecalciferols Vitamin D